Want to see AQST full AI Analyst Report?
Aquestive Therapeutics (AQST) Ownership - Who Owns Aquestive Therapeutics?
Aquestive Therapeutics (AQST) Ownership Overview
- 2.12% Insiders
- 10.65% Mutual Funds
- 1.38% Other Institutional Investors
- 9.76% ETFs
- 76.09% Public Companies and Individual Investors
The ownership structure of Aquestive Therapeutics (AQST) stock is a mix of institutional, retail, and individual investors. Approximately 21.79% of the company’s stock is owned by Institutional Investors, 2.12% is owned by Insiders, and 76.09% is owned by Public Companies and Individual Investors.
The ownership structure of Aquestive Therapeutics (AQST) stock is a mix of institutional, retail, and individual investors. Approximately 21.79% of the company’s stock is owned by Institutional Investors, 2.12% is owned by Insiders, and 76.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 15, 2026 | Daniel Barber | $105,500 | |
| Sep 15, 2026 | Daniel Barber | $120,250 | |
| Sep 09, 2026 | Peter E. Boyd | $2,201 | |
| Sep 08, 2026 | Daniel Barber | $88,073 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 8,069,373 | Institution | 6.43% | 31,389,861 |
| Vanguard | 5,424,797 | Institution | 4.32% | 21,102,460 |
| Ishares | 4,522,349 | Institution | 3.60% | 17,591,938 |
| Vanguard Index Funds | 4,481,436 | Institution | 3.57% | 17,432,786 |
| Federated Hermes Mdt Series | 1,919,230 | Institution | 1.53% | 7,465,805 |
| Spdr | 1,528,784 | Institution | 1.22% | 5,946,970 |
| Wasatch Funds Trust | 1,361,890 | Institution | 1.09% | 5,297,752 |
| Fidelity Salem Street Trust | 1,316,847 | Institution | 1.05% | 5,122,535 |
| Tiaa-cref Funds | 978,895 | Institution | 0.78% | 3,807,902 |
| Fidelity Concord Street Trust | 875,259 | Institution | 0.70% | 3,404,758 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,481,436 | Institution | 3.57% | 17,432,786 |
| Federated Hermes Mdt Series | 1,919,230 | Institution | 1.53% | 7,465,805 |
| Wasatch Funds Trust | 1,361,890 | Institution | 1.09% | 5,297,752 |
| Fidelity Salem Street Trust | 1,316,847 | Institution | 1.05% | 5,122,535 |
| Tiaa-cref Funds | 978,895 | Institution | 0.78% | 3,807,902 |
| Fidelity Concord Street Trust | 875,259 | Institution | 0.70% | 3,404,758 |
| Bridge Builder Trust | 771,303 | Institution | 0.61% | 3,000,369 |
| Vanguard Scottsdale Funds | 736,000 | Institution | 0.59% | 2,863,040 |
| Schwab Capital Trust | 306,376 | Institution | 0.24% | 1,191,803 |
| Federated Hermes Equity Funds | 144,637 | Institution | 0.12% | 562,638 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 3,403,709 | Institution | 2.71% | 15,759,173 |
| iShares, IWM ETF | 2,767,547 | Institution | 2.21% | 11,180,890 |
| Vanguard, VXF ETF | 1,277,018 | Institution | 1.02% | 5,912,593 |
| SPDR, XPH ETF | 1,133,642 | Institution | 0.90% | 4,579,914 |
| iShares, IWN ETF | 638,760 | Institution | 0.51% | 2,580,590 |
| Vanguard, VTWO ETF | 627,023 | Institution | 0.50% | 2,903,116 |
| iShares, IWO ETF | 380,074 | Institution | 0.30% | 1,478,488 |
| iShares, IWC ETF | 326,870 | Institution | 0.26% | 1,320,555 |
| Federated Hermes, FSCC ETF | 284,755 | Institution | 0.23% | 1,150,410 |
| Simplify, SURI ETF | 278,723 | Institution | 0.22% | 1,084,232 |
FAQ
Who Owns Aquestive Therapeutics (AQST)?
According to the latest TipRanks data, approximately 21.79% of the company's stock is held by institutional investors, 2.12% is held by insiders, and 76.09% is held by public companies and individual investors.
What percentage of Aquestive Therapeutics (AQST) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.79% of Aquestive Therapeutics (AQST) stock is held by institutional investors: 10.65% by mutual funds, 9.76% by ETFs and 1.38% by other institutional investors.
What percentage of Aquestive Therapeutics (AQST) stock is held by retail investors?
According to the latest TipRanks data, approximately 76.09% of Aquestive Therapeutics (AQST) stock is held by public companies and individual investors.
Who owns the most shares of Aquestive Therapeutics (AQST)?
BlackRock, Inc. owns the most shares of Aquestive Therapeutics (AQST).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
